Clinical characterization of Lassa fever: A systematic review of clinical reports and research to inform clinical trial design.
<h4>Background</h4>Research is urgently needed to reduce the morbidity and mortality of Lassa fever (LF), including clinical trials to test new therapies and to verify the efficacy and safety of the only current treatment recommendation, ribavirin, which has a weak clinical evidence base...
Saved in:
Main Authors: | Laura Merson (Author), Josephine Bourner (Author), Sulaiman Jalloh (Author), Astrid Erber (Author), Alex Paddy Salam (Author), Antoine Flahault (Author), Piero L Olliaro (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Time to reconsider the role of ribavirin in Lassa fever.
by: Alex Paddy Salam, et al.
Published: (2021) -
A standardised Phase III clinical trial framework to assess therapeutic interventions for Lassa fever.
by: Adebola Tolulope Olayinka, et al.
Published: (2022) -
Ribavirin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosing.
by: Alex P Salam, et al.
Published: (2022) -
A systematic review of the clinical profile of patients with bubonic plague and the outcome measures used in research settings.
by: Josephine Bourner, et al.
Published: (2023) -
Analysis of sociodemographic and clinical factors associated with Lassa fever disease and mortality in Nigeria
by: Adebola T. Olayinka, et al.
Published: (2022)